LRF Scientific Advisory Board Members Joined by Current and Former Grantees at the 62nd ASH Annual Meeting & Exposition
The Lymphoma Research Foundation (LRF) will return to the American Society of Hematology (ASH) Annual Meeting and Exposition, with nearly 70 LRF affiliated scientists, including past and present members of LRF’s world-leading Scientific Advisory Board (SAB) and grantees, presenting abstracts at this year’s conference.
Widely regarded as the premier event in malignant and non-malignant hematology, the virtual ASH Annual Meeting, taking place December 5-8, 2020, will provide a critical forum for leading hematologists /oncologists to present their findings to over 20,000 of their peers. Among the distinguished scientists attending, more than 50 percent of LRF Scholars – participants in LRF’s Lymphoma Scientific Mentoring Program – will present abstracts at the 2020 ASH Annual Meeting.
In addition to the Foundation’s representation through presentations, more than 40 percent of LRF grantees (including 90 percent of LRF Scholars) are authors on abstracts selected for this year’s meeting alone. In addition, LRF is represented in 596 abstracts through grantees, Lymphoma Rounds Steering Committee members, Mantle Cell Lymphoma (MCL) Consortium members, and current and former SAB members.
“The fact that we have nearly 90 percent of LRF’s Scientific Advisory Board members and more than 40 percent of LRF grantees involved in abstracts at this year’s ASH Annual Meeting speaks to the caliber of LRF’s world-class scientists and research investment,” said Andrew D. Zelenetz, MD, PhD, Chair of the LRF Scientific Advisory Board. “As Chair of this prestigious board, I am encouraged and proud of the incredible research being presented by the early career scientists we support.”
The 2020 ASH Annual Meeting also featured 10 abstracts and presentations stemming from LRF-funded research and 15 COVID-19-related research authored by LRF-affiliated scientists.
“We are incredibly proud to work with and support scientists who are making strides in advancing lymphoma research,” said Meghan Gutierrez, Chief Executive Officer of the Lymphoma Research Foundation. “We are grateful to have the expertise of our Scientific Advisory Board to guide our research investment and make a meaningful impact on the future of lymphoma research, which is evident in the number of investigators supported by LRF presenting at this year’s ASH.”
Throughout each ASH Annual Meeting, members of the Lymphoma Research Foundation Executive Team will be available for comment on ongoing ASH presentations and findings. To learn more about LRF’s research program, visit lymphoma.org/research.
Press Contact:
Kinya P. Harte
Director of Communications and Marketing
kharte@lymphoma.org
518-505-3173
